EATG » News

European Civil Society organisations request for an investigation regarding medicines shortages

The European AIDS Treatment Group and 30 other Civil Society organisations have reached out to the European Commission today to ask for a strong EU engagement to tackle the issue…

EmERGE: take part in a 5-minute survey regarding visits in your HIV clinic

How many times a year & why do people living with HIV visit an HIV clinic? Can they access telemedicine services? Help us to find out by taking part in…

EATG Newsletter (January-April 2019) is out

The new old news is on everybody's lips by now. So it is in the editorial of our latest newsletter: The risk of HIV transmission through condomless sex in gay…

EUPATI meets STEP-UP: a case study applying the EUPATI toolbox in advocates’ trainings

Summary EUPATI has developed a toolbox containing a variety of materials on medicine research and development and on the involvement of patients’ community in this process (https://www.eupati.eu/). The European AIDS…

United Nations & world leaders condemned for failure on drug policy, health and human rights

329 NGOs call for global leadership to halt global public health emergency and to end egregious human rights violations against people who use drugs.   Wednesday 1st May, Porto –…

Ageing with HIV: Testimonials of Stigma and Discrimination in Healthcare Settings

Thanks to substantial and rapid improvements in HIV treatment, it is now possible for people whose HIV is diagnosed and treated appropriately to live into old age. This is the…

EUROPEAN HEALTH CIVIL SOCIETY CALLS UPON MEMBER STATES TO SUPPORT EUROPEAN PARLIAMENT’S STRONG STAND ON HEALTH WITHIN THE EU BUDGET 2021-2027

On 1 April 2019, health civil society has published a statement calling on the Council and its Working Party on Structural Measures, responsible for the European Social Fund Plus (ESF+) file, to uphold…

STEP-UP 2013-2017 impact assessment report is out

Today, the European AIDS Treatment Group is publishing a report that aims to assess the impact the STEP-UP Training Academy programme had to its participants as well as to their…

Ageing with HIV Taskforce Meeting: Operationalising Ageing with HIV project R&D Outcomes and Identified Research Gaps

The European AIDS Treatment Group (EATG), held a meeting titled ‘Taskforce meeting: Operationalising Ageing with HIV project R&D Outcomes and identified research gaps' in Frankfurt, Germany, on 21 of March…

Civil society welcomes European Parliament push for a more ambitious EU health budget in 2021-2027

The EU Civil Society Forum on HIV/AIDS, tuberculosis (TB) and viral hepatitis and the Civil Society Forum on Drugs are encouraged to note that the European Parliament has improved the Commission…

A reflection paper dangerously lacking reflection on reaching the agreed target of HIV, viral hepatitis and TB elimination by 2030

Today, the EU Civil Society Forum on HIV/AIDS, tuberculosis and viral hepatitis issues a statement in response to European Commission's reflection paper Towards a Sustainable Europe by 2030. The paper…

The EATG endorses Life4me+ organisation and app

The European AIDS Treatment Group and Life4me.plus to fight AIDS, Hepatitis C and Tuberculosis have agreed to a mutual endorsement as partners.   Life4me+ is a community-based non-profit organisation, which…

The European AIDS Treatment Group names new Executive Director

The European AIDS Treatment Group (EATG) is delighted to introduce our new Executive Director, Pieter Vanholder. Pieter has a background in human rights and law and over a decade of…

#EU4Health: An overarching EU SDG implementation strategy is the only viable scenario

The European AIDS Treatment Group has co-signed a reaction letter to the European Commission’s Reflection Paper: Towards a Sustainable Europe by 2030, together with organisations that have endorsed the #EU4Health…

The EATG urges the Romanian government to adopt and implement the 2019-2021 HIV/AIDS National Strategic Plan

BRUSSELS - Today the European AIDS Treatment Group addresses a letter to the Romanian government in view of the new HIV/AIDS National Strategic Plan. In support of the demands and…

ОТЧЕТ ПО ДОСТУПУ К УСЛУГАМ, ОКАЗЫВАЕМЫМ ПРИ ВИРУСНОМ ГЕПАТИТЕ С, В МЕСТАХ ЛИШЕНИЯ СВОБОДЫ В ЕВРОПЕ ТЕПЕРЬ ЕСТЬ И НА РУССКОМ ЯЗЫКЕ – The report on access to HCV-related services in prison settings in Europe is now available in Russian

Отчет по доступу к услугам, оказываемым при вирусном гепатите С, в местах лишения свободы в Европе теперь есть и на русском языке. Несколько месяцев назад EATG опубликовала этот отчет и…

HepHIV2019: Meeting on implementing HIV, HBV and HCV testing guidance in the real world

In the frame of the HepHIV2019 conference taking place next week in Bucharest (28-30 January), the European AIDS Treatment Group and EuroTEST (formerly HIV in Europe) are co-hosting a multi-stakeholder breakfast…

Call for applications: Continuous Patient Education (CoPE) new call opens

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline is 11…

The EATG publishes its position paper on sex work policy

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes its stand on the sex work policy debate and approaches…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

Future of drug pricing resolution hangs in balance at World Health Assembly

23 May: The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the…

Report shows growing HIV, TB and malaria crisis in Venezuela

Venezuela faces a complex humanitarian emergency that is expanding and cascading throughout the Latin American region and around the globe. New research from ICASO and ACCSI reveal that health, economic,…

Global Fund Replenishment Conference: stepping up the fight against the HIV pandemic in the global health context

This year, France is showcasing strong commitment to the global health cause. On 10 October 2019, in Lyon, it will be hosting the Sixth Replenishment Conference of the Global Fund to…

Global Fund posts highlight importance of investment in its efforts to end HIV, TB, malaria epidemics

Leveraging technology and innovation to end AIDS and TB

Leaders from both the private and public sectors have called for fresh investment models for new technologies and the smarter roll-out of innovations to end AIDS and tuberculosis by 2030.…

Diagnostics are essential for universal health coverage to succeed

Forty years ago, 134 countries pledged to assure “Health For All” by the year 2000. They failed to deliver on that pledge. Today, at least 400 million people have no access…

HIV i-Base: HTB, conference reports and PARTNER 2 published in The Lancet

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This issue of HTB includes reports from three conferences: an early report from INTEREST, additional reports from BHIVA…

20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs: NATAP reports

20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs 14-16 May 2019, Noordwijk, the Netherlands  NATAP reports: Phase 1 results show safety and once-daily potential of…

Cocrystal Pharma commences patient enrollment for Hong Kong Phase 2a study of CC-31244 for ultra-short treatment of hepatitis C

- Humanity & Health Research Centre conducting differentiated Phase 2a study evaluating CC-31244 for the ultra-short treatment of hepatitis C (HepC) - Asia market represents one of the largest HepC…

Low rate of drug resistance to medications used for PrEP in a Canadian cohort of people with HIV

-- In rare cases, PrEP can fail if a person is infected with a drug-resistant strain of HIV -- A new study found that resistance to the drugs in PrEP…

Russia’s State Duma passes bill on child adoption by people with HIV and hepatitis C

MOSCOW, May 21 - The lower house of Russian parliament adopted a bill allowing individuals infected with HIV or Hepatitis C to adopt children in certain circumstances in a final third…

What works against self-stigma? First systematic review aims to find out

A systematic review of whether different interventions helped to overcome self-stigma in people in African and Asian countries who are living with or at risk of HIV has found that…

High prevalence of stockouts of antiretroviral medicines in South Africa

One in five public health facilities in South Africa were unable to supply at least one antiretroviral (ARV) or tuberculosis (TB) drug on the day they were contacted by researchers,…

Improving the use of methadone for drug users with TB to prevent withdrawal

-- Study finds higher dosages of methadone needed while on rifampicin -- Clinicians will be able to use the study as a guide for treatment for their patients -- Researchers…

Monkey-infecting virus may provide part of future HIV vaccine

Simian immunodeficiency virus envelope protein elicits desired anti-HIV antibody response in mice LA JOLLA, CA – A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has…

Early antiretroviral treatment may preserve key immune responses to HIV

Ragon Institute study findings could pave the way to vaccine development Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8…

Dolutegravir-based regimen associated with greater weight gain in treatment-naive individuals

Weight gain associated with antiretroviral therapy (ART), specifically integrase strand transfer inhibitor (INSTI)-based regimens, has been a focus of recent studies, some of which have identified a link between switching…

The forgotten generation?

Modern advancements such as U=U have redefined what it means to live with HIV. But, as Ross Duffin reports, for the long-term survivors the lived reality is not so rosy.…

Aging HIV population face complicated rheumatologic care

CLEVELAND — As the national population of patients who are HIV-positive continues to age, rheumatologists will be increasingly called on to manage routine care for crystal disease, osteoarthritis, soft tissue…

Tenofovir disoproxil fumarate for nucleos(t)ide analog-resistant chronic HBV

In patients with chronic hepatitis B (CHB) that is resistant to multiple nucleos(t)ide analogs (NUCs), long-term tenofovir disoproxil fumarate (TDF) monotherapy provided a virologic response in most, but it was…